Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 759,645 | 13,648,440 | 9,851,927 | 7,808,461 | 5,631,312 |
| Depreciation Amortization | 33,705 | 129,909 | 94,979 | 64,703 | 30,973 |
| Accounts receivable | 959,405 | 4,604,126 | 5,052,820 | 2,949,218 | -452,808 |
| Accounts payable and accrued liabilities | -924,841 | 90,294 | 765,774 | 206,881 | 962,287 |
| Other Working Capital | 51,201 | 4,760,691 | 6,027,790 | 3,299,552 | 557,958 |
| Other Operating Activity | -1,606,236 | -8,928,309 | -8,953,300 | -5,847,886 | -2,184,587 |
| Operating Cash Flow | $-727,121 | $14,305,150 | $12,839,990 | $8,480,929 | $4,545,134 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -31,324 | -31,926 | -30,299 |
| PPE Investments | -48,518 | -346,213 | -193,584 | -122,064 | -49,489 |
| Purchase Of Investment | -730,556 | -50,362 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 395,311 | 377,901 | 399,288 | 421,049 |
| Purchase Sale Intangibles | -10,305 | -35,928 | -26,389 | -22,880 | -18,741 |
| Other Investing Activity | -10,305 | -35,928 | -26,389 | -22,880 | -18,741 |
| Investing Cash Flow | $-789,378 | $-37,192 | $126,605 | $222,418 | $322,520 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 843 | 604 | 213 | N/A |
| Debt Repayment | N/A | -19,808 | -18,935 | -20,007 | -21,097 |
| Common Stock Issued | N/A | 116,423 | 111,296 | 117,594 | 124,003 |
| Common Stock Repurchased | -302,699 | -1,039,271 | -937,401 | -305,319 | N/A |
| Dividend Paid | N/A | -510,259 | -487,787 | -515,392 | N/A |
| Other Financing Activity | -9,983 | -43,304 | -32,129 | -23,306 | -12,793 |
| Financing Cash Flow | $-312,681 | $-1,495,375 | $-1,364,353 | $-746,217 | $90,113 |
| Exchange Rate Effect | -29,089 | 62,795 | 213,224 | 175,593 | 60,038 |
| Beginning Cash Position | 14,893,530 | 1,783,429 | 1,704,887 | 1,801,371 | 1,899,548 |
| End Cash Position | 13,035,260 | 14,618,810 | 13,520,350 | 9,934,094 | 6,917,353 |
| Net Cash Flow | $-1,858,270 | $12,835,380 | $11,815,460 | $8,132,723 | $5,017,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -727,121 | 14,305,150 | 12,839,990 | 8,480,929 | 4,545,134 |
| Capital Expenditure | -48,518 | -346,845 | -193,987 | -122,064 | -49,489 |
| Free Cash Flow | -775,639 | 13,958,305 | 12,646,003 | 8,358,865 | 4,495,645 |